Intrapulmonary drug delivery within therapeutically relevant ins

Details Intrapulmonary drug delivery within therapeutically relevant ins Intrapulmonary drug delivery within therapeutically relevant ins

1994-07-11

1996-04-23

Lewis, Aaron J.

Surgery

Liquid medicament atomizer or sprayer

12820023, 12820423, A61M 1100

Patent

active

055094040

ABSTRACT:
A method of drug delivery is disclosed wherein a patient's inspiratory flow rate and inspiratory volume are simultaneously measured using a portable, hand-held, device which may be electronic and battery-powered or mechanical. Information obtained from the measurement is used to release, into a patient's inspiratory flow path, particles of a pharmaceutically active drug. The released particles have a particle size in the range of from about 0.5 to 12 microns. The drug is released when the patient's measured inspiratory flow rate is in the range of from about 0.10 to about 2.0 liters/second and the patient's inspiratory volume is in the range of from about 0.15 to about 0.8 liters. By measuring inspiratory flow and volume and releasing within the specific parameters with respect to both flow and volume, it is possible to obtain a high degree of repeatability with respect to dosing of a patient and further to deliver a relatively high percentage of the released drug to the patient's circulatory system.

REFERENCES:
patent: 3187748 (1965-06-01), Mitchell et al.
patent: 3565070 (1971-02-01), Hamson et al.
patent: 3658059 (1972-04-01), Steil
patent: 3812854 (1974-05-01), Michaels et al.
patent: 3814297 (1974-06-01), Warren
patent: 3826413 (1974-07-01), Warren
patent: 3991304 (1976-11-01), Hillsman
patent: 4484577 (1984-11-01), Sackner et al.
patent: 4592348 (1986-06-01), Waters, IV et al.
patent: 4604847 (1986-07-01), Moulding, Jr. et al.
patent: 4648393 (1987-03-01), Landis et al.
patent: 4677975 (1987-07-01), Edgar et al.
patent: 4790305 (1988-12-01), Zoltan et al.
patent: 4803978 (1989-02-01), Johnson, IV et al.
patent: 4852582 (1989-08-01), Pell
patent: 4896832 (1990-01-01), Howlett
patent: 4926852 (1990-05-01), Zoltan et al.
patent: 4984158 (1991-01-01), Hillsman
patent: 5363842 (1994-11-01), Mishelevich et al.
"Recent Progress in Protein and Peptide Delivery by Noninvasive Routes", by Lorraine L. Wearley; Critical Reviews in Therapeutic Drug Carrier Systems, 8(4): 331-394 (1991).
"How Should A Pressurized B-Adrenergic Bronchodilator Be Inhaled?" by Stephen P. Newman et al., Eur. J. Respir. Dis. (1981) 62, 3-21.
Byron, P., Respiratory Drug Delivery, 1990, CRC Press, Inc.
Newman, S. et al, "Deposition of pressurised aerosols in the human respiratory tract", 1981, Thorax, 36:52-55.
Newman, S. et al., "How should a pressurized .beta.-adrenergic bronchodilator be inhaled?", 1981, Eur. J. Respir. Dis., 62:3-21.
Newman, S. et al., "Deposition and effects of inhalation aerosols", 1983.
Newman, S. et al., "Deposition of Pressurized Suspension Aerosols Inhaled Through Extension Devises", 1981, Am. Rev. Respir. Dis., 124:317-320.

Affiliated with

Also associated with

Rating

Intrapulmonary drug delivery within therapeutically relevant ins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intrapulmonary drug delivery within therapeutically relevant ins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intrapulmonary drug delivery within therapeutically relevant ins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2302371